These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29144790)

  • 1. Evaluation of Ki-67 Index in Core Needle Biopsies and Matched Breast Cancer Surgical Specimens.
    Ahn S; Lee J; Cho MS; Park S; Sung SH
    Arch Pathol Lab Med; 2018 Mar; 142(3):364-368. PubMed ID: 29144790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
    Romero Q; Bendahl PO; Klintman M; Loman N; Ingvar C; Rydén L; Rose C; Grabau D; Borgquist S
    BMC Cancer; 2011 Aug; 11():341. PubMed ID: 21819622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.
    Munch-Petersen HD; Rasmussen BB; Balslev E
    APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.
    Focke CM; Decker T; van Diest PJ
    Ann Surg Oncol; 2017 May; 24(5):1251-1257. PubMed ID: 28008571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
    VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
    Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.
    Chen J; Wang Z; Lv Q; Du Z; Tan Q; Zhang D; Xiong B; Zeng H; Gou J
    Pathol Oncol Res; 2017 Oct; 23(4):769-775. PubMed ID: 28074330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
    Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
    BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.
    Knutsvik G; Stefansson IM; Aziz S; Arnes J; Eide J; Collett K; Akslen LA
    PLoS One; 2014; 9(11):e112121. PubMed ID: 25375149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors.
    Petrau C; Clatot F; Cornic M; Berghian A; Veresezan L; Callonnec F; Baron M; Veyret C; Laberge S; Thery JC; Picquenot JM
    Am J Clin Pathol; 2015 Oct; 144(4):555-62. PubMed ID: 26386076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of Pre-Therapeutic Ki-67 as a Predictive Marker for Histological Response to Neoadjuvant Therapy in Breast Cancer].
    Nishimae A; Nakano Y; Nishi T; Sawai Y; Yamazaki M; Inaji H
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1491-3. PubMed ID: 26805073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer.
    Kombak FE; Şahin H; Mollamemişoğlu H; Önem İ; Kaya H; Buğdaycı O; Arıbal E
    Turk J Med Sci; 2017 Dec; 47(6):1791-1796. PubMed ID: 29306240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in measuring the Ki-67 labeling index in patients with breast cancer.
    Yamamoto S; Chishima T; Mastubara Y; Adachi S; Harada F; Toda Y; Arioka H; Hasegawa N; Kakuta Y; Sakamaki K
    Clin Breast Cancer; 2015 Feb; 15(1):e35-9. PubMed ID: 25445422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.
    Vörös A; Csörgő E; Nyári T; Cserni G
    Pathobiology; 2013; 80(3):111-8. PubMed ID: 23258384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer.
    Arima N; Nishimura R; Osako T; Nishiyama Y; Fujisue M; Okumura Y; Nakano M; Tashima R; Toyozumi Y
    Oncology; 2016; 90(1):43-50. PubMed ID: 26613521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.
    Arima N; Nishimura R; Osako T; Nishiyama Y; Fujisue M; Okumura Y; Nakano M; Tashima R; Toyozumi Y
    J Clin Pathol; 2016 Mar; 69(3):255-9. PubMed ID: 26420767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
    Kim HS; Park S; Koo JS; Kim S; Kim JY; Nam S; Park HS; Kim SI; Park BW
    PLoS One; 2016; 11(3):e0151054. PubMed ID: 26954364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].
    von Wasielewski R; Klöpper K; Lück HJ; Kreipe H
    Pathologe; 2006 Sep; 27(5):337-45. PubMed ID: 16896675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature.
    Kalvala J; Parks RM; Green AR; Cheung KL
    Histopathology; 2022 Feb; 80(3):468-484. PubMed ID: 34473381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.